Literature DB >> 8339268

Stimulation of urokinase-type plasminogen activator expression by blockage of E-cadherin-dependent cell-cell adhesion.

U H Frixen1, Y Nagamine.   

Abstract

Decreased expression of the cell-cell adhesion molecule, E-cadherin, promotes dedifferentiation and invasiveness of human carcinoma cells, whereas this process can be reversed by reexpression of E-cadherin (U. H. Frixen et al., J. Cell Biol., 113: 173-185, 1991; J. H. Schipper et al., Cancer Res., 51: 6328-6337, 1991). In this work we studied the involvement of extracellular matrix-degrading proteases in E-cadherin-dependent tumor cell invasion. When T47D and MCF-7 human differentiated breast carcinoma cells were treated with the E-cadherin antibody DECMA (decompacting monoclonal antibody) the cells dissociated from each other and lost their epithelioid morphology, paralleled with a rise in the secretion of urokinase-type plasminogen activator (uPA) into the extracellular milieu as determined by zymography. The stimulation of uPA required protein and RNA synthesis. Furthermore, when DECMA-treated T47D cells were cultured on artificial collagen matrices the induced invasiveness correlated with accumulation of uPA in the culture medium, and uPA antibodies inhibited this invasion process. Actin filaments which are thought to be associated with the cytoplasmic part of E-cadherin were disrupted after treatment of T47D cells with DECMA. These results suggest a link between cell-cell adhesion, the integrity of actin filaments, and the regulation of uPA biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8339268

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors.

Authors:  M Y Hsu; F E Meier; M Nesbit; J Y Hsu; P Van Belle; D E Elder; M Herlyn
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

2.  Repression of E-cadherin by the polycomb group protein EZH2 in cancer.

Authors:  Q Cao; J Yu; S M Dhanasekaran; J H Kim; R-S Mani; S A Tomlins; R Mehra; B Laxman; X Cao; J Yu; C G Kleer; S Varambally; A M Chinnaiyan
Journal:  Oncogene       Date:  2008-09-22       Impact factor: 9.867

3.  Cell density-dependent downregulation of urokinase-type plasminogen activator in normal but not in transformed human epidermal keratinocytes.

Authors:  S Inndorf; M J Bechtel; J Reinartz; M D Kramer
Journal:  Arch Dermatol Res       Date:  1996-11       Impact factor: 3.017

4.  Regulation of matrilysin expression in cells of squamous cell carcinoma by E-cadherin-mediated cell-cell contact.

Authors:  A H Borchers; L A Sanders; G T Bowden
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

5.  Low E-cadherin and beta-catenin expression correlates with increased spontaneous and artificial lung metastases of murine carcinomas.

Authors:  T Akimoto; S Kawabe; A Grothey; L Milas
Journal:  Clin Exp Metastasis       Date:  1999-03       Impact factor: 5.150

6.  Platelet-activating factor regulates cadherin-catenin adhesion system expression and beta-catenin phosphorylation during Kaposi's sarcoma cell motility.

Authors:  Mariarosaria Boccellino; Giovanni Camussi; Alfonso Giovane; Luigi Ferro; Vincenzo Calderaro; Ciro Balestrieri; Lucio Quagliuolo
Journal:  Am J Pathol       Date:  2005-05       Impact factor: 4.307

Review 7.  Regulation of E-cadherin: does hypoxia initiate the metastatic cascade?

Authors:  I R Beavon
Journal:  Mol Pathol       Date:  1999-08

8.  Relationship between the expression of E-, N-cadherins and beta-catenin and tumor grade in astrocytomas.

Authors:  Satoshi Utsuki; Yuichi Sato; Hidehiro Oka; Benio Tsuchiya; Sachio Suzuki; Kiyotaka Fujii
Journal:  J Neurooncol       Date:  2002-05       Impact factor: 4.130

9.  E-cadherin surface levels in epithelial growth factor-stimulated cells depend on adherens junction protein shrew-1.

Authors:  Julia Christina Gross; Alexander Schreiner; Knut Engels; Anna Starzinski-Powitz
Journal:  Mol Biol Cell       Date:  2009-06-10       Impact factor: 4.138

10.  Urokinase-Type Plasminogen Activator Protects Cerebral Cortical Neurons from Soluble Aβ-Induced Synaptic Damage.

Authors:  Ariel Diaz; Paola Merino; Ji-Dong Guo; Manuel A Yepes; Patrick McCann; Tapasya Katta; Elise M Tong; Enrique Torre; Srikant Rangaraju; Manuel Yepes
Journal:  J Neurosci       Date:  2020-04-24       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.